Skip to main content
Beta Drugs Limited logo

Beta Drugs Limited — Investor Relations & Filings

Ticker · BETA ISIN · INE351Y01019 LEI · 984500A89888DB9E6T57 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 431 across all filing types
Latest filing 2020-09-30 AGM Information
Country IN India
Listing National Stock Exchange of India BETA

About Beta Drugs Limited

https://www.betadrugslimited.com

Beta Drugs Limited specializes in the development, manufacture, and marketing of oncology formulations. The company provides a comprehensive portfolio of anti-cancer drugs across various therapeutic segments, including cytotoxic injectables, lyophilized products, tablets, and capsules. Its manufacturing capabilities encompass a wide range of oncology treatments such as chemotherapy agents and supportive care medications. The organization operates advanced production facilities designed to meet international quality standards, focusing on high-potency active pharmaceutical ingredients and finished dosage forms. The company serves diverse markets through its own branded products and contract manufacturing services, aiming to provide affordable and high-quality cancer care solutions. Its core competency lies in its specialized focus on the oncology niche and its integrated approach to pharmaceutical production.

Recent filings

Filing Released Lang Actions
Shareholders meeting
AGM Information Classification · 95% confidence The document is a detailed summary of the proceedings of the 15th Annual General Meeting (AGM) of Beta Drugs Limited held on 30th September 2020. It includes information about the meeting's conduct, attendance, agenda items, voting procedures, and resolutions passed. The content focuses on the AGM event itself rather than the full annual report or financial statements. The document is not a full Annual Report (10-K), nor is it an earnings release or other financial report. It is a summary of the AGM proceedings, which fits the definition of AGM Information (AGM-R). The document length (8732 characters) supports it being a full summary rather than a brief announcement. Therefore, the appropriate classification is AGM Information (AGM-R).
2020-09-30 English
Trading Window
Regulatory Filings Classification · 100% confidence The document text is extremely short (65 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, no report content, no announcements, or any regulatory information. Given the lack of content, this cannot be classified as any substantive report or announcement. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings with no meaningful content.
2020-09-30 English
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a short announcement dated 24th September 2020 from Beta Drugs Limited addressed to the National Stock Exchange of India. It reports the outcome of a Board Meeting where the Board approved shifting financial facilities from one bank to another. The document references compliance with SEBI regulations and is clearly an announcement of a board decision rather than a detailed report. It does not contain financial statements or detailed management discussion. The content fits the category of Board/Management Information (MANG) as it relates to a board decision about financial facilities. The document length is short (1488 characters), consistent with an announcement rather than a full report.
2020-09-24 English
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited reporting the outcome of a Board Meeting held on 24th September 2020. The content specifically mentions the approval by the Board of Directors to shift financial facilities from one bank to another. There is no financial data, no detailed report, no audit information, no earnings data, or any other detailed disclosures. The document is an announcement of a board decision, which fits the category of Board/Management Information (MANG). The document length is short (1488 characters), and it is not a report publication announcement or a certification. Therefore, the classification is MANG with high confidence.
2020-09-24 English
Board Meeting — Other business matters
Board/Management Information Classification · 95% confidence The document is a short letter addressed to the National Stock Exchange of India Limited, notifying about a forthcoming Board Meeting scheduled for 24/09/2020. The main agenda mentioned is shifting financial facilities from one bank to another. The document is brief (1325 characters) and serves as an announcement of a board meeting rather than the meeting materials or minutes themselves. It does not contain financial data, audit information, or detailed management discussion. This fits the category of Board/Management Information (MANG), which includes announcements of changes or meetings of the board of directors or senior management.
2020-09-21 English
Shareholders meeting
AGM Information Classification · 100% confidence The document is a Notice of Annual General Meeting (AGM) for Beta Drugs Limited scheduled for September 30, 2020. It includes details about the meeting agenda, such as adoption of financial statements, appointment of directors, and remuneration approval. It also provides instructions for attending the AGM via video conferencing due to COVID-19, procedural notes, and other administrative details. The document does not contain the actual financial statements or detailed financial performance data but is rather a formal notice convening the AGM and informing shareholders about the meeting and its logistics. Therefore, it fits the category of AGM Information (AGM-R).
2020-09-07 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.